📌 Key Takeaways
- Topic: What Is Silicon Oxide? SiO vs SiO₂ Differences and Applications Explained
- Keywords: silica sand for glass
- Published: 2026-11-20 04:33:01
- Field: Silica (SiO₂) raw materials · Inorganic non-metallic materials · Chemicals
What Is Mesoporous Silica? Structure, Pore Size and Applications in Drug Delivery and Catalysis
- Precipitated Silica Supplier: How to Compare Grades, Pricing and Reliability
- 35. Barguilla I., Candela-Noguera V., Oliver P., Annangi B., Díez P., Aznar E., Martínez-Máñez R., Marcos R., Hernández A., Marcos M.D. Toxicological Profiling and Long-Term Influences of Bare, PEGylated- and Galacto-Oligosaccharide-Functionalized Mesoporous Silica Nanoparticles. Int. J. Mol. Sci. 2023;24:16158. doi: 10.3390/ijms242216158. [ DOI ] [ PMC free post ] [ PubMed ] [ Google Scholar ]
- Spherical Silica Powder: Specifications, Particle Sizes and How to Choose the Right Grade
- 8. Ahmed H., Gomte S.S., Prathyusha E., A P., Agrawal M., Alexander A. Biomedical applications of mesoporous silica nanoparticles as a drug delivery carrier. J. Drug Deliv. Sci. Technol. 2022;76:103729. doi: 10.1016/j.jddst.2022.103729. [ DOI ] [ Google Scholar ]
- Is Silicon Dioxide Toxic? Safety of Amorphous vs Crystalline Forms Explained
- 83. Shendge R.S., Dimote R.K. Formulation and optimization of mesoporous silica loaded gel containing extract of Rosmarinus officinalis for treatment of acute wound healing. Eur. J. Med. Chem. Rep. 2024;11:100155. doi: 10.1016/j.ejmcr.2024.100155. [ DOI ] [ Google Scholar ]
- Silica Mesh Size Chart: Mesh to Micron Conversion and How to Choose
- DE doesn't lose its effectiveness in the long run. If it stays in place, it'll work for you.
What Is Silica Sand? Composition, Grades, Mesh Sizes and Industrial Uses
What is silica (SiO₂)?
silica free sample
What is the difference between fumed silica and precipitated silica?
synthetic amorphous silica
What drives silica raw material prices?
fused silica Targeted therapy, aiming, for instance, at antitumor treatments, can be divided into active and passive forms [ 72, 73 ]. Passive targeting is based on higher vascularity and higher vascular permeability of the tumor, as well as inflamed tissues, compared to physiological ones [ 73, 74 ]. Additionally, the lymphatic circulation of the tumor shows decreased efficiency [ 25 ], which led to easier accumulation of nanoparticles in the tumor or inflamed tissues [ 10, 27, 72, 74 ]. This passive accumulation is normally called "ELVIS" (Extravasation through Leaky Vasculature and later Inflammatory cell-mediated Sequestration) [ 72, 74 ]. From the facet of surface qualities, negatively charged nanoparticles accumulate less effectively inside cells, due to the negatively charged cell membrane, which slows down the cellular uptake, so, in this case, a neutral surface charge is more favorable [ 25 ]. In contrast, active targeting can be accomplished by functionalizing the outer surface of the silica carriers [ 10, 27, 72 ], where molecules are attached to the surface of the carriers that specifically bind to certain cell surface ligands and receptors, which are characteristic of tumor-, but not of healthy cells. This selective method provides more effective treatment and reduces the side impacts of cytotoxic APIs on healthy cells and tissues [ 10, 27 ]. The most recent findings on active targeting possibilities are summarized in Table 3. García-Fernández et al. prepared a mesoporous silica-based nanocarrier loaded with dexamethasone and capped with a particular protein to actively target the TNFR1 receptor, which is overexpressed in pro-inflammatory macrophages [ 72 ]. Since the carriers are preferably internalized by these macrophages, the cargo is released in a controlled manner, during enzymatic hydrolysis, thus preventing premature drug release, thanks to the gatekeepers. The targeting talent was tested in vitro with activated macrophages. On the other hand, the therapeutic efficiency was tested in vivo in mouse models. The researchers observed greater therapeutic impacts and fewer adverse side influences than in the case of free dexamethasone. To sum up, dexamethasone-loaded MSN has been effectively developed to actively target the lungs in acute lung injury (ALI), and this result may also be promising in other lung diseases (COPD, asthma) [ 72 ]. Teruel et al. presented a novel approach in oral inflammatory bowel sickness (IBD) therapy, using functionalized magnetic mesoporous silica microparticles [ 75 ].
/news/article.htmlDisclaimer: Prices and data are for reference only and do not constitute purchasing or investment advice. Please credit the source when republishing.